A spokesperson for the Department of Health and Human Services confirmed that Dr. Vinay Prasad, who led the FDA’s Center for ...

On June 7, the U.S. Food and Drug Administration granted "accelerated approval" to Biogen's new Alzheimer's medication, aducanumab, two years after the company halted its first set of Phase 3 ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. In 2022, three Food and Drug Administration inspectors ...